Citadel Advisors’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-132,475
| Closed | -$2.39M | – | 15794 |
|
|
2025
Q1 | $2.39M | Buy |
132,475
+107,382
| +428% | +$1.91M | ﹤0.01% | 5188 |
|
|
2024
Q4 | $438K | Sell |
25,093
-87,950
| -78% | -$1.19M | ﹤0.01% | 8849 |
|
|
2024
Q3 | $1.3M | Buy |
113,043
+64,566
| +133% | +$741K | ﹤0.01% | 6327 |
|
|
2024
Q2 | $549K | Sell |
48,477
-35,779
| -42% | -$476K | ﹤0.01% | 7866 |
|
|
2024
Q1 | $1.21M | Sell |
84,256
-20,159
| -19% | -$286K | ﹤0.01% | 6552 |
|
|
2023
Q4 | $1.43M | Buy |
104,415
+43,153
| +70% | +$454K | ﹤0.01% | 5979 |
|
|
2023
Q3 | $498K | Sell |
61,262
-257,723
| -81% | -$2.11M | ﹤0.01% | 8081 |
|
|
2023
Q2 | $2.41M | Buy |
318,985
+60,354
| +23% | +$461K | ﹤0.01% | 4827 |
|
|
2023
Q1 | $2.07M | Buy |
258,631
+126,753
| +96% | +$1.3M | ﹤0.01% | 5304 |
|
|
2022
Q4 | $1.5M | Sell |
131,878
-48,302
| -27% | -$527K | ﹤0.01% | 6036 |
|
|
2022
Q3 | $1.57M | Sell |
180,180
-22,851
| -11% | -$237K | ﹤0.01% | 6059 |
|
|
2022
Q2 | $2.02M | Buy |
203,031
+80,886
| +66% | +$814K | ﹤0.01% | 5526 |
|
|
2022
Q1 | $1.23M | Buy |
122,145
+45,409
| +59% | +$483K | ﹤0.01% | 7233 |
|
|
2021
Q4 | $973K | Buy |
76,736
+60,130
| +362% | +$783K | ﹤0.01% | 8037 |
|
|
2021
Q3 | $208K | Buy |
+16,606
| New | +$225K | ﹤0.01% | 11911 |
|
|
2021
Q2 | – | Sell |
-18,321
| Closed | -$252K | – | 14597 |
|
|
2021
Q1 | $252K | Buy |
+18,321
| New | +$284K | ﹤0.01% | 11214 |
|
|
2020
Q4 | – | Sell |
-19,507
| Closed | -$248K | – | 11645 |
|
|
2020
Q3 | $248K | Buy |
+19,507
| New | +$245K | ﹤0.01% | 8454 |
|
Citadel Advisors's PTVE Position: Q2 2025 in Review
Citadel Advisors sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q2 2025, closing a stake of 132,475 shares — an estimated $2.39M sold.
Citadel Advisors first reported a position in PTVE in Q3 2020 and held it in 17 quarters. The position peaked at $2.41M in Q2 2023. 0 funds tracked by Wall St. Rank hold PTVE as of Q2 2025.
- Citadel Advisors reported no remaining Pactiv Evergreen Inc. Common stock position as of Q2 2025 after selling out during the quarter.
- Citadel Advisors sold 132,475 Pactiv Evergreen Inc. Common stock shares in Q2 2025, an estimated $2.39M.
- Citadel Advisors first reported a position in Pactiv Evergreen Inc. Common stock in Q3 2020 and held it in 17 quarters.
- Citadel Advisors's Pactiv Evergreen Inc. Common stock position peaked at $2.41M in Q2 2023.
- 0 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q2 2025.
Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.